These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 27594385)

  • 1. Poly I:C primes the suppressive function of human palatine tonsil-derived MSCs against Th17 differentiation by increasing PD-L1 expression.
    Cho KA; Park M; Kim YH; Ryu KH; Woo SY
    Immunobiology; 2017 Feb; 222(2):394-398. PubMed ID: 27594385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tonsil-derived mesenchymal stem cells (T-MSCs) prevent Th17-mediated autoimmune response via regulation of the programmed death-1/programmed death ligand-1 (PD-1/PD-L1) pathway.
    Kim JY; Park M; Kim YH; Ryu KH; Lee KH; Cho KA; Woo SY
    J Tissue Eng Regen Med; 2018 Feb; 12(2):e1022-e1033. PubMed ID: 28107610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential TLR activation of murine mesenchymal stem cells generates distinct immunomodulatory effects in EAE.
    Vega-Letter AM; Kurte M; Fernández-O'Ryan C; Gauthier-Abeliuk M; Fuenzalida P; Moya-Uribe I; Altamirano C; Figueroa F; Irarrázabal C; Carrión F
    Stem Cell Res Ther; 2016 Oct; 7(1):150. PubMed ID: 27724984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal stem cells suppress T cells by inducing apoptosis and through PD-1/B7-H1 interactions.
    Yan Z; Zhuansun Y; Liu G; Chen R; Li J; Ran P
    Immunol Lett; 2014 Nov; 162(1 Pt A):248-55. PubMed ID: 25281059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal stem cells increase skin graft survival time and up-regulate PD-L1 expression in splenocytes of mice.
    Moravej A; Geramizadeh B; Azarpira N; Zarnani AH; Yaghobi R; Kalani M; Khosravi M; Kouhpayeh A; Karimi MH
    Immunol Lett; 2017 Feb; 182():39-49. PubMed ID: 28069488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal Stromal Cell Secretion of Programmed Death-1 Ligands Regulates T Cell Mediated Immunosuppression.
    Davies LC; Heldring N; Kadri N; Le Blanc K
    Stem Cells; 2017 Mar; 35(3):766-776. PubMed ID: 27671847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of pro-inflammatory cytokines on immunophenotype, differentiation capacity and immunomodulatory functions of human mesenchymal stem cells.
    Pourgholaminejad A; Aghdami N; Baharvand H; Moazzeni SM
    Cytokine; 2016 Sep; 85():51-60. PubMed ID: 27288632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal stem cells repress Th17 molecular program through the PD-1 pathway.
    Luz-Crawford P; Noël D; Fernandez X; Khoury M; Figueroa F; Carrión F; Jorgensen C; Djouad F
    PLoS One; 2012; 7(9):e45272. PubMed ID: 23028899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different roles of PD-L1 and FasL in immunomodulation mediated by human placenta-derived mesenchymal stem cells.
    Gu YZ; Xue Q; Chen YJ; Yu GH; Qing MD; Shen Y; Wang MY; Shi Q; Zhang XG
    Hum Immunol; 2013 Mar; 74(3):267-76. PubMed ID: 23261407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal Stem Cells Upregulate the Expression of PD-L1 But Not VDR in Dendritic Cells.
    Moravej A; Karimi MH; Geramizadeh B; Azarpira N; Zarnani AH; Yaghobi R; Khosravi M; Kalani M; Gharesi-Fard B
    Immunol Invest; 2017 Jan; 46(1):80-96. PubMed ID: 27736253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Programmed Death-Ligand 1 Expression Potentiates the Immune Modulatory Function Of Myeloid-Derived Suppressor Cells in Systemic Lupus Erythematosus.
    Park MJ; Baek JA; Choi JW; Jang SG; Kim DS; Park SH; Cho ML; Kwok SK
    Front Immunol; 2021; 12():606024. PubMed ID: 33986739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human iPSC-MSC-Derived Xenografts Modulate Immune Responses by Inhibiting the Cleavage of Caspases.
    Li CL; Leng Y; Zhao B; Gao C; Du FF; Jin N; Lian QZ; Xu SY; Yan GL; Xia JJ; Zhuang GH; Fu QL; Qi ZQ
    Stem Cells; 2017 Jul; 35(7):1719-1732. PubMed ID: 28520232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tonsil-derived mesenchymal stromal cells produce CXCR2-binding chemokines and acquire follicular dendritic cell-like phenotypes under TLR3 stimulation.
    Ryu JH; Park M; Kim BK; Ryu KH; Woo SY
    Cytokine; 2015 Jun; 73(2):225-35. PubMed ID: 25794662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human graft-derived mesenchymal stromal cells potently suppress alloreactive T-cell responses.
    de Mare-Bredemeijer EL; Mancham S; Verstegen MM; de Ruiter PE; van Gent R; O'Neill D; Tilanus HW; Metselaar HJ; de Jonge J; Kwekkeboom J; Hall SR; van der Laan LJ
    Stem Cells Dev; 2015 Jun; 24(12):1436-47. PubMed ID: 25744002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The PD-1/PD-L1 inhibitory pathway is altered in pre-eclampsia and regulates T cell responses in pre-eclamptic rats.
    Tian M; Zhang Y; Liu Z; Sun G; Mor G; Liao A
    Sci Rep; 2016 Jun; 6():27683. PubMed ID: 27277012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In patients with chronic aplastic anemia, bone marrow-derived MSCs regulate the Treg/Th17 balance by influencing the Notch/RBP-J/FOXP3/RORγt pathway.
    Li H; Wang L; Pang Y; Jiang Z; Liu Z; Xiao H; Chen H; Ge X; Lan H; Xiao Y
    Sci Rep; 2017 Feb; 7():42488. PubMed ID: 28195151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stem cells from patients with rheumatoid arthritis display impaired function in inhibiting Th17 cells.
    Sun Y; Deng W; Geng L; Zhang L; Liu R; Chen W; Yao G; Zhang H; Feng X; Gao X; Sun L
    J Immunol Res; 2015; 2015():284215. PubMed ID: 25918734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The immunomodulatory function of equine MSCs is enhanced by priming through an inflammatory microenvironment or TLR3 ligand.
    Cassano JM; Schnabel LV; Goodale MB; Fortier LA
    Vet Immunol Immunopathol; 2018 Jan; 195():33-39. PubMed ID: 29249315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-25 Mediates Transcriptional Control of PD-L1 via STAT3 in Multipotent Human Mesenchymal Stromal Cells (hMSCs) to Suppress Th17 Responses.
    Wang WB; Yen ML; Liu KJ; Hsu PJ; Lin MH; Chen PM; Sudhir PR; Chen CH; Chen CH; Sytwu HK; Yen BL
    Stem Cell Reports; 2015 Sep; 5(3):392-404. PubMed ID: 26321145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal stem cells inhibit human Th17 cell differentiation and function and induce a T regulatory cell phenotype.
    Ghannam S; Pène J; Moquet-Torcy G; Jorgensen C; Yssel H
    J Immunol; 2010 Jul; 185(1):302-12. PubMed ID: 20511548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.